Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kevin Odell"'
Autor:
Jennifer Costello, Kevin Odell
Publikováno v:
Cardiology. 142(1)
Autor:
Henry J. Henk, Shalabh Singhal, Lien Vo, Kenneth Tuell, Feng Cao, Jeffrey Trocio, Chad Patel, Jack Mardekian, Kevin Odell, Kwanza Price, Prianka Singh, Wilson Tan, Sands George Harry
Publikováno v:
Current medical research and opinion. 34(3)
Objective To evaluate inpatient oral anticoagulant (OAC) treatment, discharge location, and post-discharge OAC treatment for patients hospitalized with non-valvular atrial fibrillation (NVAF). Research design and methods Retrospective study using cla
Autor:
Chad Patel, Allison Keshishian, Alpesh Amin, Oluwaseyi Dina, Jeffrey Trocio, Qisu Zhang, Kevin Odell, Lien Vo
Publikováno v:
Journal of medical economics. 21(3)
Aims: To compare the risk of all-cause hospitalization and hospitalizations due to stroke/systemic embolism (SE) and major bleeding, as well as associated healthcare costs for non-valvular atrial fibrillation (NVAF) patients initiating apixaban, dabi
Publikováno v:
Journal of Managed Care Pharmacy. 20:1047-1056
Overactive bladder (OAB) and related conditions, such as urge urinary incontinence (UI), can interfere with work, leisure activities, and healthy sleep patterns.To report (a) employee urinary antispasmodic (UA) medication persistence and adherence; (
Publikováno v:
Journal of Occupational & Environmental Medicine. 56:266-269
OBJECTIVE Quantify incremental employee medical, pharmacy, sick leave, short- and long-term disability, and workers' compensation costs, absence days, and turnover associated with urge urinary incontinence (UUI) in employees. METHODS This retrospecti
Autor:
Joseph C. Cappelleri, Rachel Halpern, Kevin Odell, Tim Bancroft, Alesia Sadosky, Carolyn Martin
Publikováno v:
Journal of managed carespecialty pharmacy. 22(2)
Pharmacy cost-saving programs often aim to reduce costs for members and payers by encouraging use of lower-tier or generic medications and lower-cost sales channels. In 2010, a national U.S. health plan began a novel pharmacy program directed at redu
Autor:
Alpesh Amin, Allison Keshishian, Lin Xie, Onur Baser, Kwanza Price, Lien Vo, Prianka Singh, Amanda Bruno, Jack Mardekian, Wilson Tan, Shalabh Singhal, Chad Patel, Kevin Odell, Jeffrey Trocio
Publikováno v:
Circulation. 132
Objective: The study aim was to compare major bleeding risk and health care costs after initiating oral anticoagulants (OACs) for treatment-naïve non-valvular atrial fibrillation (NVAF) patients. Methods: Patients in the Medicare advantage populatio
Publikováno v:
Journal of Urology. 189
Autor:
Chad Patel, Jack Mardekian, Henry J. Henk, Lien Vo, Kenneth Tuell, Kwanza Price, Shalabh Singhal, Mario Mendoza, Kevin Odell, Jeffrey Trocio
Publikováno v:
Journal of the American College of Cardiology. 67:708
Using claims data for commercial and Medicare Advantage enrollees linked to hospital electronic health records (EHR) and social security administration's death master file, we describe the stroke risk, inpatient oral anticoagulant (OAC) treatment, di
Autor:
Allison Keshishian, Chad Patel, Lin Xie, Kwanza Price, Shalabh Singhal, Jack Mardekian, Prianka Singh, Jeffrey Trocio, Amanda Bruno, Kevin Odell, Wilson Tan, Amin N Alpesh, Lien Vo, Onur Baser
Publikováno v:
Blood. 126:745-745
INTRODUCTION: Recent large randomized controlled trials have shown that novel oral anticoagulants (NOACs) are at least as effective as warfarin for risk reduction of stroke or systemic embolism in patients with non-valvular atrial fibrillation (NVAF)